Advisory Services Network’s Perspective Therapeutics CATX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-44
Closed -$183 2541
2026
Q1
$183 Buy
+44
New +$186 ﹤0.01% 4578
2025
Q4
Sell
-67
Closed -$230 2182
2025
Q3
$230 Buy
+67
New +$244 ﹤0.01% 4189
2024
Q1
Sell
-100
Closed -$402 1792
2023
Q4
$402 Buy
+100
New +$281 ﹤0.01% 3655
2023
Q2
Sell
-100
Closed -$638 1790
2023
Q1
$638 Hold
100
﹤0.01% 3699
2022
Q4
$247 Buy
+100
New +$329 ﹤0.01% 3827
2021
Q3
Sell
-100
Closed -$1K 1680
2021
Q2
$1K Buy
+100
New +$876 ﹤0.01% 3429

Other funds holding CATX

Advisory Services Network's CATX Position: Q2 2026 in Review

Advisory Services Network sold out of Perspective Therapeutics (CATX) in Q2 2026, closing a stake of 44 shares — an estimated $183 sold.

Advisory Services Network first reported a position in CATX in Q2 2021 and held it in 6 quarters. The position peaked at $1K in Q2 2021. 132 funds tracked by Wall St. Rank hold CATX as of Q2 2026.

  • Advisory Services Network reported no remaining Perspective Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Advisory Services Network sold 44 Perspective Therapeutics shares in Q2 2026, an estimated $183.
  • Advisory Services Network first reported a position in Perspective Therapeutics in Q2 2021 and held it in 6 quarters.
  • Advisory Services Network's Perspective Therapeutics position peaked at $1K in Q2 2021.
  • 132 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q2 2026.

Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.